
| NAME | DATE | TM | OPP | MIN | PTS | REB | AST | STL | BLK | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | OREB | DREB | TOV | PF | +/- | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  |  C. LeVert   | 12/16/2016    |  BKN | @    |  ORL | 11    | 5    | 4    | 2    | 1    | 0    | 2    | 3    | 66.7    | 1    | 2    | 50.0    | 0    | 0    | 83.3    | 0    | 4    | 0    | 1    | +4    | |
| 2 |  |  C. LeVert   | 4/1/2017    |  BKN | vs    |  ORL | 20    | 9    | 3    | 0    | 0    | 0    | 4    | 8    | 50.0    | 1    | 4    | 25.0    | 0    | 0    | 56.3    | 0    | 3    | 0    | 1    | -6    | |
| 3 |  |  C. LeVert   | 4/6/2017    |  BKN | @    |  ORL | 27    | 20    | 4    | 1    | 0    | 0    | 7    | 12    | 58.3    | 2    | 4    | 50.0    | 4    | 4    | 100.0    | 72.7    | 0    | 4    | 0    | 1    | -10    | 
| 4 |  |  C. LeVert   | 10/20/2017    |  BKN | vs    |  ORL | 27    | 9    | 1    | 2    | 2    | 1    | 4    | 11    | 36.4    | 0    | 4    | 0.0    | 1    | 3    | 33.3    | 36.5    | 0    | 1    | 3    | 2    | +12    | 
| 5 |  |  C. LeVert   | 10/24/2017    |  BKN | @    |  ORL | 29    | 15    | 8    | 5    | 0    | 0    | 4    | 11    | 36.4    | 2    | 6    | 33.3    | 5    | 5    | 100.0    | 56.8    | 2    | 6    | 2    | 3    | +5    | 
| 6 |  |  C. LeVert   | 1/1/2018    |  BKN | vs    |  ORL | 27    | 15    | 5    | 8    | 2    | 0    | 6    | 15    | 40.0    | 1    | 2    | 50.0    | 2    | 3    | 66.7    | 46.0    | 1    | 4    | 5    | 3    | +2    | 
| 7 |  |  C. LeVert   | 3/28/2018    |  BKN | @    |  ORL | 25    | 16    | 3    | 6    | 1    | 0    | 6    | 14    | 42.9    | 2    | 6    | 33.3    | 2    | 2    | 100.0    | 53.8    | 1    | 2    | 1    | 3    | 0    | 
| 8 |  |  C. LeVert   | 2/24/2020    |  BKN | vs    |  ORL | 34    | 19    | 5    | 8    | 1    | 0    | 8    | 21    | 38.1    | 3    | 6    | 50.0    | 0    | 1    | 0.0    | 44.3    | 1    | 4    | 4    | 4    | +1    | 
| 9 |  |  C. LeVert   | 7/31/2020    |  BKN | vs    |  ORL | 28    | 17    | 2    | 7    | 1    | 0    | 7    | 17    | 41.2    | 0    | 4    | 0.0    | 3    | 4    | 75.0    | 45.3    | 2    | 0    | 4    | 0    | -26    | 
| 10 |  |  C. LeVert   | 4/9/2021    |  IND | @    |  ORL | 29    | 11    | 7    | 3    | 1    | 1    | 4    | 12    | 33.3    | 0    | 2    | 0.0    | 3    | 3    | 100.0    | 41.3    | 1    | 6    | 1    | 5    | +6    | 
| 11 |  |  C. LeVert   | 4/25/2021    |  IND | @    |  ORL | 30    | 18    | 3    | 6    | 1    | 0    | 7    | 14    | 50.0    | 1    | 2    | 50.0    | 3    | 3    | 100.0    | 58.7    | 0    | 3    | 0    | 1    | +25    | 
| 12 |  |  C. LeVert   | 2/2/2022    |  IND | vs    |  ORL | 35    | 26    | 5    | 5    | 2    | 1    | 10    | 24    | 41.7    | 1    | 6    | 16.7    | 5    | 8    | 62.5    | 47.2    | 0    | 5    | 2    | 2    | -7    | 
| 13 |  |  C. LeVert   | 3/28/2022    |  CLE | vs    |  ORL | 33    | 8    | 7    | 6    | 1    | 1    | 4    | 15    | 26.7    | 0    | 4    | 0.0    | 0    | 0    | 26.7    | 1    | 6    | 2    | 2    | -13    | |
| 14 |  |  C. LeVert   | 4/5/2022    |  CLE | @    |  ORL | 31    | 11    | 4    | 4    | 0    | 0    | 4    | 8    | 50.0    | 0    | 1    | 0.0    | 3    | 4    | 75.0    | 56.4    | 1    | 3    | 3    | 1    | +1    | 
| 15 |  |  C. LeVert   | 10/26/2022    |  CLE | vs    |  ORL | 33    | 12    | 2    | 6    | 1    | 0    | 3    | 12    | 25.0    | 3    | 7    | 42.9    | 3    | 6    | 50.0    | 41.0    | 0    | 2    | 5    | 3    | +20    | 
| 16 |  |  C. LeVert   | 12/2/2022    |  CLE | vs    |  ORL | 24    | 5    | 1    | 4    | 2    | 0    | 2    | 7    | 28.6    | 1    | 6    | 16.7    | 0    | 0    | 35.7    | 0    | 1    | 1    | 2    | +17    | |
| 17 |  |  C. LeVert   | 4/4/2023    |  CLE | @    |  ORL | 36    | 19    | 3    | 0    | 1    | 0    | 7    | 10    | 70.0    | 5    | 6    | 83.3    | 0    | 0    | 95.0    | 0    | 3    | 1    | 1    | -5    | |
| 18 |  |  C. LeVert   | 2/22/2024    |  CLE | vs    |  ORL | 27    | 6    | 2    | 2    | 1    | 1    | 2    | 10    | 20.0    | 0    | 2    | 0.0    | 2    | 2    | 100.0    | 27.6    | 0    | 2    | 2    | 2    | -10    | 
| 19 |  |  C. LeVert   | 11/1/2024    |  CLE | vs    |  ORL | 22    | 13    | 3    | 7    | 0    | 0    | 5    | 12    | 41.7    | 2    | 7    | 28.6    | 1    | 2    | 50.0    | 50.5    | 0    | 3    | 2    | 2    | +18    | 
| 20 |  |  C. LeVert   | 2/10/2025    |  ATL | @    |  ORL | 32    | 18    | 8    | 2    | 0    | 0    | 6    | 11    | 54.5    | 3    | 7    | 42.9    | 3    | 4    | 75.0    | 70.5    | 0    | 8    | 0    | 2    | +6    | 
| 21 |  |  C. LeVert   | 2/20/2025    |  ATL | vs    |  ORL | 28    | 13    | 4    | 0    | 2    | 0    | 6    | 13    | 46.2    | 0    | 3    | 0.0    | 1    | 4    | 25.0    | 44.0    | 0    | 4    | 0    | 4    | -8    | 
| 22 |  |  C. LeVert   | 4/8/2025    |  ATL | @    |  ORL | 30    | 13    | 6    | 0    | 0    | 0    | 4    | 11    | 36.4    | 2    | 6    | 33.3    | 3    | 3    | 100.0    | 52.8    | 1    | 5    | 2    | 3    | -11    | 
| 23 |  |  C. LeVert   | 10/29/2025    |  DET | vs    |  ORL | 16    | 4    | 1    | 2    | 0    | 0    | 1    | 5    | 20.0    | 0    | 2    | 0.0    | 2    | 3    | 66.7    | 31.6    | 0    | 1    | 1    | 1    | +6    | 
| Average | 27.6 | 13.1 | 4.0 | 3.7 | 0.9 | 0.2 | 4.9 | 12.0 | 40.9 | 1.3 | 4.3 | 30.3 | 2.0 | 2.8 | 71.9 | 49.6 | 0.5 | 3.5 | 1.8 | 2.1 | 1.2 | ||||||
| Total | 634 | 302 | 91 | 86 | 20 | 5 | 113 | 276 | 40.9 | 30 | 99 | 30.3 | 46 | 64 | 71.9 | 49.6 | 11 | 80 | 41 | 49 | +27 | 
ORTG
115.6
15th
DRTG
129.8
30th
NETRTG
-14.2
29th
3P%
35.4
15th